2018
DOI: 10.1111/codi.14249
|View full text |Cite
|
Sign up to set email alerts
|

Prevention and treatment of parastomal hernia: a position statement on behalf of the Association of Coloproctology of Great Britain and Ireland

Abstract: There is a lack of high quality evidence for many domains in the prevention and treatment of PSH but the results of several studies are awaited. WHAT DOES THIS PAPER ADD TO THE LITERATURE?: Parastomal hernias are a common and debilitating condition following stoma formation. This position statement from ACPGBI details the current evidence base and ongoing research for the prevention, diagnosis and management of parastomal hernias.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(3 citation statements)
references
References 101 publications
(125 reference statements)
0
3
0
Order By: Relevance
“…However, only 24% of patients with an ostomy remain asymptomatic in the long term [5]. Subsequently, the Association of Coloproctology of Great Britain and Ireland identified that the prevention and treatment of PSHs are the second most important non-cancer-related issues due to high recurrence rates after hernia repair [6]. Although prophylactic mesh for PSH prevention has been advocated [7][8][9] a recent randomized controlled trial has shown that reinforcing meshes to prevent PSH formation cannot be recommended [10].…”
Section: Introductionmentioning
confidence: 99%
“…However, only 24% of patients with an ostomy remain asymptomatic in the long term [5]. Subsequently, the Association of Coloproctology of Great Britain and Ireland identified that the prevention and treatment of PSHs are the second most important non-cancer-related issues due to high recurrence rates after hernia repair [6]. Although prophylactic mesh for PSH prevention has been advocated [7][8][9] a recent randomized controlled trial has shown that reinforcing meshes to prevent PSH formation cannot be recommended [10].…”
Section: Introductionmentioning
confidence: 99%
“…The proportion of stoma patients who develop a PSH varies widely in the published literature due to heterogeneity in the definition and mode of diagnosis. Both the EHS and the Association of Coloproctology of Great Britain and Ireland guidelines suggest a range of 5%-50% [5,6]. However, a 2018 systematic review of stoma-related morbidity in randomized trials reported a range of 41.5%-88.2% in patients with an end colostomy [7], which reflects findings from a randomized controlled trial on the use of prophylactic mesh in permanent colostomy formation which reported that 93.8% of the patients in the control group developed a PSH [8].…”
mentioning
confidence: 99%
“…Although prophylactic mesh may delay the onset of parastomal hernia in patients with an end colostomy [13][14][15][16], the application of prophylactic meshes in clinical practice is low [17]. For non-surgical preventive interventions, for example physical or abdominal training, lifting restrictions or wearing support garments, there is no firm evidence [18]. Surgical treatment of parastomal bulging is technically challenging with significant morbidity and recurrence [19][20][21][22].…”
mentioning
confidence: 99%